Kaplan–Meier analysis revealed that the increased mRNA expression levels of PRMT1/3/5/6 were remarkably associated with shorter survival in HCC patients, whilst HCC patients with higher mRNA expression level of PRMT8 or PRMT9 had a better prognosis (p < .05) (Figure S2). This evidence concerns the gene PRMT1 and hepatocellular carcinoma.